Literature DB >> 25550541

Is relative quantification dispensable for the measurement of microRNAs as serum biomarkers in germ cell tumors?

Meike Spiekermann1, Klaus-Peter Dieckmann2, Thomas Balks2, Jörn Bullerdiek3, Gazanfer Belge4.   

Abstract

BACKGROUND: Classical biomarkers α-fetoprotein, β-human chorionic gonadotropin and lactate dehydrogenase (AFP, bHCG and LDH) are elevated in only 60% of all testicular germ cell tumor (TGCT) patients. microRNAs (miRNAs) are a novel class of useful biomarkers in cancer and miRNAs of the miR-371-3 cluster were proven to be valuable markers for TGCT patients.
MATERIALS AND METHODS: We compared the Ct and ΔCt values of miR-371-3 by real time PCR (qPCR) with and without 18S rRNA for normalization. Expression of miR-371a-3p, miR-372 and miR-373-3p was measured in 25 TGCTs, 4 non-TGCTs and 17 age-matched male controls.
RESULTS: A highly positive correlation between Ct and ΔCt values was found in all samples. The highest correlation was found for miR-371a-3p (R2: 0.956).
CONCLUSION: RESULTS show that qPCR can be used without endogenous control for analyzing miR-371-3 in the serum of patients with testicular cancer and male controls if the technical procedure is performed under controlled conditions. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Biomarker; endogenous control; germ cell tumors; microRNA; real time PCR; testicular cancer

Mesh:

Substances:

Year:  2015        PMID: 25550541

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series.

Authors:  Petra Anheuser; Arlo Radtke; Christian Wülfing; Jennifer Kranz; Gazanfer Belge; Klaus-Peter Dieckmann
Journal:  Urol Int       Date:  2017-06-07       Impact factor: 2.089

Review 2.  The translational potential of microRNAs as biofluid markers of urological tumours.

Authors:  Annika Fendler; Carsten Stephan; George M Yousef; Glen Kristiansen; Klaus Jung
Journal:  Nat Rev Urol       Date:  2016-11-02       Impact factor: 14.432

Review 3.  Data Normalization Strategies for MicroRNA Quantification.

Authors:  Heidi Schwarzenbach; Andreia Machado da Silva; George Calin; Klaus Pantel
Journal:  Clin Chem       Date:  2015-09-25       Impact factor: 8.327

4.  Serum Level of microRNA-375-3p Is Not a Reliable Biomarker of Teratoma.

Authors:  Gazanfer Belge; Francesca Grobelny; Cord Matthies; Arlo Radtke; Klaus-Peter Dieckmann
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

Review 5.  Testicular cancer.

Authors:  Liang Cheng; Peter Albers; Daniel M Berney; Darren R Feldman; Gedske Daugaard; Timothy Gilligan; Leendert H J Looijenga
Journal:  Nat Rev Dis Primers       Date:  2018-10-05       Impact factor: 52.329

6.  "Future-Proofing" Blood Processing for Measurement of Circulating miRNAs in Samples from Biobanks and Prospective Clinical Trials.

Authors:  Matthew J Murray; Hannah L Watson; Dawn Ward; Shivani Bailey; Marta Ferraresso; James C Nicholson; Vincent J Gnanapragasam; Benjamin Thomas; Cinzia G Scarpini; Nicholas Coleman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-12-18       Impact factor: 4.254

Review 7.  The present and future of serum diagnostic tests for testicular germ cell tumours.

Authors:  Matthew J Murray; Robert A Huddart; Nicholas Coleman
Journal:  Nat Rev Urol       Date:  2016-10-18       Impact factor: 14.432

8.  Locoregional surgical treatment improves the prognosis in patients with primary metastatic testicular cancer with a single bone or brain metastasis.

Authors:  Mierxiati Abudurexiti; Yao Zhu; Ding-Wei Ye
Journal:  Mol Clin Oncol       Date:  2020-06-03

9.  Cellular origin of microRNA-371a-3p in healthy males based on systematic urogenital tract tissue evaluation.

Authors:  W P A Boellaard; A J M Gillis; G J L H van Leenders; H Stoop; T van Agthoven; L C J Dorssers; M Dinkelman-Smit; J L Boormans; L H J Looijenga
Journal:  Andrology       Date:  2019-02-20       Impact factor: 3.842

10.  A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.

Authors:  Matthew J Murray; Emma Bell; Katie L Raby; Martin A Rijlaarsdam; Ad J M Gillis; Leendert H J Looijenga; Helen Brown; Benoit Destenaves; James C Nicholson; Nicholas Coleman
Journal:  Br J Cancer       Date:  2015-12-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.